ORIC offering history
Every offering-related filing in Oric Pharmaceuticals, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 414 filings back to Dec 13, 2019.
| Date | Filing | What it means | |
|---|---|---|---|
| Feb 23, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 24, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jun 20, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 11, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| May 28, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Mar 11, 2024 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Feb 2, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jan 26, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jan 22, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Dec 28, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 15, 2023 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jun 27, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Dec 21, 2022 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Apr 27, 2022 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 6, 2021 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| May 6, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 13, 2020 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Nov 12, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 12, 2020 | S-1MEF → | REGISTERED | S-1MEF registration — capacity to sell shares, not a sale yet |
| Nov 10, 2020 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Aug 5, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Apr 24, 2020 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Apr 23, 2020 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Apr 23, 2020 | S-1MEF → | REGISTERED | S-1MEF registration — capacity to sell shares, not a sale yet |
| Apr 23, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 20, 2020 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Feb 28, 2020 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
ORIC offering FAQ
When did ORIC last execute an offering?
Per SEC filings, Oric Pharmaceuticals, Inc.'s most recent priced offering document is a 424B5 filed 2026-02-23. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did ORIC last announce or register an offering?
The most recent registration is a S-3 filed 2025-06-11. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.